Your fight against advanced
kidney cancer may start or continue here
OPDIVO is an FDA-approved immunotherapy that is the foundation for three different uses in advanced kidney cancer, or renal cell carcinoma (RCC)
Your fight against advanced
kidney cancer may start or continue here
OPDIVO is an FDA-approved immunotherapy that is the foundation for three different uses in advanced kidney cancer, or renal cell carcinoma (RCC)
Actor portrayals.
OPDIVO + YERVOY is a treatment option for certain adults with previously untreated kidney cancer that has spread (advanced RCC)
OPDIVO, in combination with CABOMETYX® (cabozantinib), is a treatment option for certain adults with previously untreated kidney cancer that has spread (advanced RCC)
OPDIVO is a treatment option for certain adults with kidney cancer (RCC) when your cancer has spread or grown after treatment with other cancer medications
OPDIVO and OPDIVO-based combination treatments will not work for everyone. Individual results may vary.